Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness
- PMID: 18286480
- DOI: 10.1002/jcp.21417
Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness
Abstract
We are interested in two aspects of a given type of metastatic breast cancer: which potentially cancer-relevant genes are expressed and which factors determine invasiveness. Using reverse transcription real-time PCR, we detected gene expression of 26 matrix metalloproteinases (MMPs) in MDA-MB-231 breast cancer cells, including those of MMP-12, MMP-16 variant 2, MMP-19, MMP-20, MMP-21, MMP-23, MMP-24, MMP-25, MMP-25 variant 2, MMP-L1, MMP-26, MMP-27, and MMP-28, in contrast to the 13 MMPs detected until now in these cells. We found that MMP genes are expressed at widely different levels in these cells, over five orders of magnitude. After individual siRNA-induced depletions, we found that six additional species of cancer cell MMPs promote invasiveness in MDA-MB-231 cells: MMP-3, MMP-11, MMP-12, MMP-17, MMP-19, and MMP-23, thus raising the total to 12 endogenous MMPs which do so in these cells. The data support the conclusion that some cancer cell MMPs, although expressed at low levels, are needed for cancer trait in MDA-MB-231 cells, and that several endogenous MMPs play non-redundant roles in this process. The mRNA level of MMP-11, but not of other MMPs, rose substantially following individual siRNA-targeted depletion of cancer cell MMP-17 mRNA, while no MMP mRNA increased appreciably after degradation of other MMP mRNAs. This supports the conclusion that MMP-17 may be a member of an intracellular signaling pathway which downregulates MMP-11 mRNA.
(c) 2008 Wiley-Liss, Inc.
Similar articles
-
New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.J Cell Physiol. 2008 Dec;217(3):739-44. doi: 10.1002/jcp.21548. J Cell Physiol. 2008. PMID: 18651563
-
Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.Anticancer Res. 2001 Nov-Dec;21(6A):3821-8. Anticancer Res. 2001. PMID: 11911253
-
New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.J Cell Physiol. 2011 Dec;226(12):3378-84. doi: 10.1002/jcp.22694. J Cell Physiol. 2011. PMID: 21344390
-
[Matrix metalloproteinases and breast cancer].Ai Zheng. 2002 Sep;21(9):1029-34. Ai Zheng. 2002. PMID: 12508555 Review. Chinese.
-
The other side of MMPs: protective roles in tumor progression.Cancer Metastasis Rev. 2007 Dec;26(3-4):717-24. doi: 10.1007/s10555-007-9089-4. Cancer Metastasis Rev. 2007. PMID: 17717634 Review.
Cited by
-
Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking.Cell Mol Life Sci. 2014 Apr;71(7):1191-210. doi: 10.1007/s00018-013-1431-0. Epub 2013 Aug 3. Cell Mol Life Sci. 2014. PMID: 23912897 Free PMC article. Review.
-
Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion.Am J Pathol. 2009 Dec;175(6):2625-36. doi: 10.2353/ajpath.2009.090543. Epub 2009 Nov 5. Am J Pathol. 2009. PMID: 19893036 Free PMC article.
-
Regulation and involvement of matrix metalloproteinases in vascular diseases.Front Biosci (Landmark Ed). 2016 Jan 1;21(1):89-118. doi: 10.2741/4378. Front Biosci (Landmark Ed). 2016. PMID: 26709763 Free PMC article. Review.
-
Human Skin Aging and the Anti-Aging Properties of Retinol.Biomolecules. 2023 Nov 4;13(11):1614. doi: 10.3390/biom13111614. Biomolecules. 2023. PMID: 38002296 Free PMC article. Review.
-
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.Breast Cancer Res. 2013 Feb 13;15(1):R12. doi: 10.1186/bcr3385. Breast Cancer Res. 2013. PMID: 23407024 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous